- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Top Stock Picks from Analysts
Hong Kong Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
13
Companies which are more than 50% undervalued based on analyst price target.
13 companies
Mirxes Holding
Market Cap: HK$15.7b
A micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China.
2629
HK$59.75
7D
7.7%
1Y
n/a
Shanghai Haohai Biological Technology
Market Cap: HK$11.7b
Shanghai Haohai Biological Technology Co., Ltd.
6826
HK$26.76
7D
-4.7%
1Y
-16.5%
Ascletis Pharma
Market Cap: HK$11.4b
A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.
1672
HK$11.51
7D
9.6%
1Y
965.7%
TYK Medicines
Market Cap: HK$6.0b
A clinical-stage biopharmaceutical company, research, development and commercialization of pharmaceutical products.
2410
HK$15.82
7D
0%
1Y
-48.5%
Viva Biotech Holdings
Market Cap: HK$5.4b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$2.56
7D
2.0%
1Y
265.7%
Laekna
Market Cap: HK$5.4b
An investing holding company, engages in the discovering, development, and commercialization of therapies for patients with cancer, metabolic diseases, and liver fibrosis in the People’s Republic of China, the United States of America, and South Korea.
2105
HK$12.82
7D
-6.3%
1Y
148.4%
AIM Vaccine
Market Cap: HK$5.1b
Engages in the research and development, manufacture, and sale of vaccine products for human use in the People’s Republic of China.
6660
HK$4.14
7D
-7.2%
1Y
-7.0%
ImmuneOnco Biopharmaceuticals (Shanghai)
Market Cap: HK$4.5b
A biotechnology company, engages in the research and development of immuno-oncology therapies in the People’s Republic of China.
1541
HK$11.15
7D
-3.5%
1Y
123.0%
VISEN Pharmaceuticals
Market Cap: HK$4.4b
An investment holding company, engages in the development and commercialization of paradigm-shifting endocrine therapies in the Chinese Mainland.
2561
HK$41.66
7D
-6.3%
1Y
n/a
Cutia Therapeutics
Market Cap: HK$3.1b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$8.79
7D
-9.4%
1Y
-42.3%
Jacobson Pharma
Market Cap: HK$3.0b
Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.
2633
HK$1.48
7D
1.4%
1Y
142.6%
Transcenta Holding
Market Cap: HK$2.1b
A clinical stage biopharmaceutical company, engages in the discovery, research, development, manufacture, and commercialization of various drugs for unmet medical needs in the People’s Republic of China and the United States.
6628
HK$4.60
7D
8.7%
1Y
342.3%
Sirnaomics
Market Cap: HK$1.5b
An RNA therapeutics biopharmaceutical company, discovers and develops drugs for indications with medical needs.
2257
HK$14.51
7D
-14.6%
1Y
359.2%